Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.
about
Adjuvant chemotherapy for invasive bladder cancer (individual patient data)Neo-adjuvant chemotherapy for invasive bladder cancerBladder Preservation for Muscle Invasive Bladder CancerSaudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladderRole of systemic chemotherapy in urothelial urinary bladder cancerMultimodal management of muscle-invasive bladder cancerManagement of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgeryCD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.Refining patient selection for neoadjuvant chemotherapy before radical cystectomyMeta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer.Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial.Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients.Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guidelineSaudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer.Recent advances in the diagnosis and treatment of bladder cancer.Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum.Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.Saudi Oncology Society clinical management guidelines for urinary bladder cancer.Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.Role of systemic peri-operative chemotherapy in management of transitional cell carcinoma of bladder.Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.Genetic susceptibility to bladder cancer risk and outcome.Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder.Low ANXA10 expression is associated with disease aggressiveness in bladder cancerTrends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.Treatment of invasive bladder cancer: lessons from the past and perspective for the future.Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapyManagement of muscle-invasive bladder cancer in the elderly.Treatment of muscle-invasive bladder cancer: progress and new challenges.Update on the management of invasive bladder cancer 2012.Prognostic implications of preoperative anemia in urothelial carcinoma: A meta-analysis.Neoadjuvant chemotherapy in invasive bladder cancer.Recent advances in the treatment of bladder cancer.
P2860
Q24243900-A3CB91D1-40BC-4D35-B158-77984C655170Q24247506-BD102DBA-CA25-423A-89CF-268E97BD4887Q26744750-34CC4AED-2471-49D0-9C12-02BA59DAC800Q26747775-DA6FFDBD-150C-4D51-A7CB-AC2878811EEDQ27010323-23BBD811-0AE7-478F-A49A-C93535F3CEC5Q27011624-F0628766-FFFF-45AB-9B53-7378A4DD421EQ28074930-0F486329-F5A4-47BF-89A0-841A624A6D1AQ30408689-8017E4F8-3089-44CB-BDAF-C386CACBDBAAQ30408866-E834D154-85DD-4EB0-9078-AB280973007BQ30976026-4E6960B1-017A-4B78-8343-30EA0BAA8189Q31024148-FB9242BE-8262-4BB3-A2BB-91521B25DF1DQ33360846-B5F13877-8527-4A11-AA04-1BF8E2CC5B84Q33396809-831E0CB9-9859-4C4F-A3D0-C79DCFC12D97Q33407274-FFD62CCA-05C0-436A-AB7E-ABE66053AB82Q33670824-68646374-681E-4915-91A1-D23E307F11EFQ33865150-FAF548EC-7A33-470E-AF2E-C0DD1BEAFF05Q33911932-804E8B2C-B0CE-4348-9F83-E337AB479356Q34023055-2D91EDCE-A67E-488E-830E-263546B40169Q34437299-FD5AF8A9-BEAF-4411-964F-A5441D6C48B1Q34552725-2B1C012B-779D-424B-BAD8-669D733E96ADQ34670535-90C372CF-1D18-4135-8999-0869AF7720B7Q34816825-0DAECABE-8F16-4BD9-AEEC-CB2E04671A15Q34997367-E08DB096-3BDE-4826-AB98-C9E8952FA146Q35109085-62889523-B36E-4885-8218-05494F7F5947Q35125750-C3CD7FC0-1163-486C-BDA1-BF3861B69032Q35174486-7C22003C-4355-4C7B-AA2E-8283DD516B65Q35212792-BF0E4CAC-6AB3-4CE5-AE3D-57F41B8F70FAQ35603639-893C2915-7760-417F-B94C-14C4E138E37FQ35620687-49ED1DE0-944D-42C2-9E86-58C129C1F9DAQ35748071-E6D18220-49E8-4A7E-9AA6-54B9FEA87B33Q35866471-78DA1FDB-3C02-47AC-A18D-3A2638B74761Q35873130-96247067-7120-4B98-8FB6-C5CCABFD7A97Q35905142-33AF7895-1EBA-410B-975E-A7BDEA9F64F5Q35957178-4B29170F-C086-4C05-A7EF-2664EF29235DQ35987747-A15F35EF-6D4A-41D6-A6B6-98FD1E5B4092Q35987756-304C4FB3-638A-456A-A3AA-A95A55FD60BDQ36171243-7B27F446-4CB2-4D2C-A769-1CED3062F1AAQ36275572-56F05112-D622-4DA4-AF1A-82F1CA9B4B40Q36334882-3C5C4791-858A-4593-854B-10E5C4A8147AQ36334892-321612E5-92E0-40A4-9AF1-A7B28E332672
P2860
Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Neoadjuvant chemotherapy in in ...... atic review and meta-analysis.
@ast
Neoadjuvant chemotherapy in in ...... atic review and meta-analysis.
@en
type
label
Neoadjuvant chemotherapy in in ...... atic review and meta-analysis.
@ast
Neoadjuvant chemotherapy in in ...... atic review and meta-analysis.
@en
prefLabel
Neoadjuvant chemotherapy in in ...... atic review and meta-analysis.
@ast
Neoadjuvant chemotherapy in in ...... atic review and meta-analysis.
@en
P1433
P1476
Neoadjuvant chemotherapy in in ...... atic review and meta-analysis.
@en
P2093
Advanced Bladder Cancer Meta-analysis Collaboration
P304
P356
10.1016/S0140-6736(03)13580-5
P407
P577
2003-06-01T00:00:00Z